PEC2001
/ PharmaEssentia
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
October 02, 2026
PEC2001, a differentiated dual LILRB1/LILRB2 antagonist, reprograms myeloid immunity and enhances anti-tumor activity
(SITC 2026)
- No abstract available
Oncology • LILRB1
1 to 1
Of
1
Go to page
1